Alibhai Imran Nizamudin 4
4 · Tvardi Therapeutics, Inc. · Filed Dec 18, 2025
Insider Transaction Report
Form 4
Alibhai Imran Nizamudin
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-12-16+47,500→ 47,500 totalExercise: $4.20Exp: 2035-12-16→ Common Stock (47,500 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on December 16, 2026, and the balance of the shares subject to the option shall vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous service through each applicable vesting date.